Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Anticancer Research|April 3, 2020
Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic FactorsTakaya Yamamoto, Yuzuru Niibe, Yasuo Matsumoto, et al.Journal of Radiation Research|September 2, 2011
The radiotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin treatment is an effective therapeutic option in patients with advanced or metastatic bladder cancerMasaomi Ikeda, Kazumasa Matsumoto, Yuzuru Niibe, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 5, 2020
Significant reduction of oncologic pulmonary death by local control for pulmonary oligometastases treated with stereotactic body radiotherapyTakaya Yamamoto, Yuzuru Niibe, Kazunari Yamada, et al.Pulmonary Medicine|September 20, 2012
Radiotherapy for oligometastases and oligo-recurrence of bone in prostate cancerKen-Ichi Tabata, Yuzuru Niibe, Takefumi Satoh, et al.Japanese Journal of Clinical Oncology|March 12, 2013
High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTROHideomi Yamashita, Yuzuru Niibe, Takafumi Toita, et al.Japanese Journal of Clinical Oncology|January 6, 2007
Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)Yuzuru Niibe, Kazushige Hayakawa, Shinpei Tsunoda, et al.Japanese Journal of Clinical Oncology|October 10, 2009
Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer: the individual case reviewTakafumi Toita, Masahiko Oguchi, Tatsuya Ohno, et al.Journal of Radiation Research|September 17, 2020
Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinomaTakaya Yamamoto, Yuzuru Niibe, Yasuo Matsumoto, et al.Cancer Medicine|October 6, 2020
Factors related to primary cancer death and non-primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastasesTakaya Yamamoto, Yuzuru Niibe, Yasuo Matsumoto, et al.Anticancer Research|May 7, 2017
Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal CancerKeiichi Jingu, Yukinori Matsuo, Hiroshi Onishi, et al.Pageof 6